Climb Global Solutions (NASDAQ:CLMB) & 908 Devices (NASDAQ:MASS) Critical Review

Climb Global Solutions (NASDAQ:CLMB) and 908 Devices (NASDAQ:MASS) are both small-cap technology companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk.

Earnings and Valuation

This table compares Climb Global Solutions and 908 Devices”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Climb Global Solutions	$652.52 million	0.83	$21.33 million	$1.12	26.04
908 Devices	$56.20 million	7.39	$19.49 million	($0.95)	-10.58

Climb Global Solutions has higher revenue and earnings than 908 Devices. 908 Devices is trading at a lower price-to-earnings ratio than Climb Global Solutions, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

Climb Global Solutions has a beta of 1.09, meaning that its stock price is 9% more volatile than the S&P 500. Comparatively, 908 Devices has a beta of 0.68, meaning that its stock price is 32% less volatile than the S&P 500.

Institutional & Insider Ownership

49.7% of Climb Global Solutions shares are held by institutional investors. Comparatively, 88.1% of 908 Devices shares are held by institutional investors. 3.8% of Climb Global Solutions shares are held by insiders. Comparatively, 28.2% of 908 Devices shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares Climb Global Solutions and 908 Devices’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Climb Global Solutions	2.88%	18.87%	5.04%
908 Devices	-56.96%	-12.54%	-8.87%

Analyst Ratings

This is a summary of current ratings and price targets for Climb Global Solutions and 908 Devices, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Climb Global Solutions	0	2	2	1	2.80
908 Devices	1	0	2	0	2.33

Climb Global Solutions currently has a consensus target price of $31.00, suggesting a potential upside of 6.27%. 908 Devices has a consensus target price of $12.50, suggesting a potential upside of 24.38%. Given 908 Devices’ higher possible upside, analysts plainly believe 908 Devices is more favorable than Climb Global Solutions.

Summary

Climb Global Solutions beats 908 Devices on 10 of the 14 factors compared between the two stocks.

About Climb Global Solutions

Climb Global Solutions Inc. operates as a value-added information technology (IT) distribution and solutions company in the United States, Canada, Europe, the United Kingdom, and internationally. It operates in two segments, Distribution and Solutions. The company distributes technical software to corporate and value-added resellers, consultants, and systems integrators under the name Climb Channel Solutions; and provides cloud solutions and resells software, hardware, and services under the name Grey Matter. It also resells computer software and hardware developed by others, as well as provides technical services to end user customers. In addition, the company offers a line of products from various software vendors; and tools for virtualization/cloud computing, security, networking, storage and infrastructure management, application lifecycle management, and other technically sophisticated domains, as well as computer hardware. It markets its products through its own web sites, local and on-line seminars, events, webinars, and social media, as well as direct email and printed materials. The company was formerly known as Wayside Technology Group, Inc. and changed its name to Climb Global Solutions Inc. in October 2022. Climb Global Solutions Inc. was incorporated in 1982 and is headquartered in Eatontown, New Jersey.

About 908 Devices

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.